Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New CAR t therapy trial hopes to outsmart tough leukemia in kids

NCT ID NCT06847269

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 20 times

Summary

This study is for children, teens, and young adults with a type of leukemia that has not responded to standard treatments. It uses a special therapy where a patient's own immune cells are collected, modified to recognize and attack cancer cells, and then given back. The main goal is to find the best dose of chemotherapy given before the cell infusion and to see how long the cells last in the body. The study will also track side effects and how well the treatment works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Jude Children's Research Hospital

    RECRUITING

    Memphis, Tennessee, 38105, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.